We detected attenuation of atherosclerosis in HFHC diet–fed mice with PCSK9-AAV–induced atherosclerosis following 18 weeks of semaglutide treatment, yet we were not able to detect regression of aortic atherosclerosis using a 6-week semaglutide treatment regimen. The gene discussed is PCSK9; the disease is aortic atherosclerosis.